Detalles de la búsqueda
1.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(2): 139-150, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642080
2.
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
Int J Cancer
; 152(4): 705-712, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830214
3.
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Br J Haematol
; 203(5): 792-802, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691005
4.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
N Engl J Med
; 383(26): 2526-2537, 2020 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369355
5.
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group.
Ann Hematol
; 102(8): 2119-2126, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392368
6.
Impaired adaptive immune response in COVID-19 convalescent patients with hematological malignancies.
Eur J Haematol
; 110(4): 396-406, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36562254
7.
The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes.
Int J Mol Sci
; 24(5)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902139
8.
Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia.
Int J Mol Sci
; 23(17)2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076988
9.
Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?
Support Care Cancer
; 29(1): 323-330, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32361829
10.
Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
Int J Mol Sci
; 22(24)2021 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948194
11.
Infection and expression of Toll-like receptors in lymphoid malignancy patients after autologous stem cell transplantation.
Cent Eur J Immunol
; 46(4): 463-469, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35125944
12.
Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria: Multicenter Analysis by the Polish Adult Leukemia Group.
Biol Blood Marrow Transplant
; 26(10): 1833-1839, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32512214
13.
Pattern of human monocyte subpopulations in health and disease.
Scand J Immunol
; 92(1): e12883, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243617
14.
The comparison of effectiveness and safety between different biosimilars of G-CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto-PBSCT).
J Clin Apher
; 35(1): 4-8, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31663634
15.
Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma.
J Clin Apher
; 35(4): 246-254, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298020
16.
Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Hematol Oncol
; 37(4): 383-391, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31026087
17.
Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.
Eur J Haematol
; 100(5): 465-474, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427355
18.
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).
BMC Cancer
; 15: 508, 2015 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26152663
19.
Azacitidine in outpatient treatment - single center experience.
Contemp Oncol (Pozn)
; 19(6): 467-70, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26843844
20.
The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.
Leuk Lymphoma
; 65(1): 55-61, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888870